Featured news in The Life Sciences Report
|
|
|
Celgene Corp. (CELG:NASDAQ)
Celgene (CELG) Q4 Earnings: Will the Stock Pull a Surprise? (1/20/2017)
|
|
view
|
|
|
Celgene Corp. (CELG:NASDAQ)
Blog Coverage PharmAthene and Altimmune Announced a Merger; Set to Establish Immunotherapeutic Collaboration (1/20/2017)
|
|
view
|
|
|
|
|
MiMedx Group Inc. (MDXG:NASDAQ)
Lifshitz & Miller Law Firm Announces Investigation of Ally Financial Inc., Amphastar Pharmaceuticals, Inc., Lannett Company, Inc., Live Ventures Incorporated, MiMedx Group, Inc., Seattle Genetics, Inc., Teligent, Inc., TerraVia Holdings, Inc., and Zimmer (1/19/2017)
|
|
view
|
|
|
|
|
Sunesis Pharmaceuticals Inc. (SNSS:NASDAQ)
Synergy (SGYP) Trulance Wins FDA Approval for Constipation (1/20/2017)
|
|
view
|
|
|
Sunesis Pharmaceuticals Inc. (SNSS:NASDAQ)
Mallinckrodt to Pay $100M Fine to FTC for Questcor Matter (1/19/2017)
|
|
view
|
|
|
Sunesis Pharmaceuticals Inc. (SNSS:NASDAQ)
Aduro (ADRO) Inks License Agreement with Stanford University (1/20/2017)
|
|
view
|
|
|
|
|
Caladrius Biosciences Inc. (CLBS:NASDAQ)
Caladrius Biosciences Inc. (CLBS) Gives Up 3.32% at Midday on January 18, Pressuring Health Care Stocks (1/18/2017)
|
|
view
|
|
|
|
|
RXi Pharmaceuticals Corp. (PHIO:NASDAQ)
Health Care Sector Feels Weight of 4.92% Slide in Early Trading of RXi Pharmaceuticals Corporation (RXII) on January 18 (1/18/2017)
|
|
view
|
|
|
RXi Pharmaceuticals Corp. (PHIO:NASDAQ)
RXi Pharmaceuticals Corporation (RXII) Gives Up 4.78% at Midday on January 18, Pressuring Health Care Stocks (1/18/2017)
|
|
view
|
|
|
|
|
Regeneus Ltd. (RGS:ASX)
Announces Q4/16 News Update (1/17/2017)
|
|
view
|
|
|
|
|
Athersys Inc. ()
Athersys Subsidiary and Leading Animal Health Company Enter Into Research and Option Agreement for Cell Therapy (1/18/2017)
|
|
view
|
|
|
|
|
Celgene Corp. (CELG:NASDAQ)
4 Top Biotech Mutual Funds for 2017 (1/18/2017)
|
|
view
|
|
|
|
|
Sunesis Pharmaceuticals Inc. (SNSS:NASDAQ)
Kura Oncology Starts Dosing Patients in Phase II CMML Study (1/18/2017)
|
|
view
|